{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T06:40:03Z","timestamp":1752216003756,"version":"3.41.2"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,10]]},"DOI":"10.7759\/cureus.87701","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T06:12:46Z","timestamp":1752214366000},"source":"Crossref","is-referenced-by-count":0,"title":["Comparative Effectiveness of Dual Antiplatelet Therapy Versus Single Antiplatelet Therapy in Patients With Acute Stroke"],"prefix":"10.7759","author":[{"given":"Awais","family":"Aslam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Hamza","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hifza","family":"Ishtiaq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiza","family":"Ali Akbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syeda","family":"Wajiha Batool","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samreen","family":"Ameen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marriam","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2016.10.011","article-title":"Systematic review and meta-analysis of dual versus single antiplatelet therapy in carotid interventions","volume":"53","author":"Barkat M","year":"2017","unstructured":"Barkat M, Hajibandeh S, Hajibandeh S, Torella F, Antoniou GA. Systematic review and meta-analysis of dual versus single antiplatelet therapy in carotid interventions. Eur J Vasc Endovasc Surg. 2017, 53:53-67. 10.1016\/j.ejvs.2016.10.011","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.carrev.2018.03.008","article-title":"Dual antiplatelet therapy versus single antiplatelet therapy after transaortic valve replacement: meta-analysis","volume":"19","author":"Alrifai A","year":"2018","unstructured":"Alrifai A, Soud M, Kabach A, et al.. Dual antiplatelet therapy versus single antiplatelet therapy after transaortic valve replacement: meta-analysis. Cardiovasc Revasc Med. 2018, 19:47-52. 10.1016\/j.carrev.2018.03.008","journal-title":"Cardiovasc Revasc Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000377","article-title":"Benefits and risks of dual versus single antiplatelet therapy for secondary stroke prevention: a systematic review for the 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack","volume":"52","author":"Brown DL","year":"2021","unstructured":"Brown DL, Levine DA, Albright K, et al.. Benefits and risks of dual versus single antiplatelet therapy for secondary stroke prevention: a systematic review for the 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack. Stroke. 2021, 52:e468-79. 10.1161\/STR.0000000000000377","journal-title":"Stroke"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-023-01266-2","article-title":"Contemporary antiplatelet and anticoagulant therapies for secondary stroke prevention: a narrative review of current literature and guidelines","volume":"23","author":"Bhatia K","year":"2023","unstructured":"Bhatia K, Ladd LM, Carr KH, et al.. Contemporary antiplatelet and anticoagulant therapies for secondary stroke prevention: a narrative review of current literature and guidelines. Curr Neurol Neurosci Rep. 2023, 23:235-62. 10.1007\/s11910-023-01266-2","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2018.07.083","article-title":"Dual versus single antiplatelet therapy after coronary artery bypass graft surgery: an updated meta-analysis","volume":"269","author":"Cardoso R","year":"2018","unstructured":"Cardoso R, Knijnik L, Whelton SP, et al.. Dual versus single antiplatelet therapy after coronary artery bypass graft surgery: an updated meta-analysis. Int J Cardiol. 2018, 269:80-8. 10.1016\/j.ijcard.2018.07.083","journal-title":"Int J Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215340","article-title":"Clopidogrel with aspirin in acute minor stroke or transient ischemic attack","volume":"369","author":"Wang Y","year":"2013","unstructured":"Wang Y, Wang Y, Zhao X, et al.. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013, 369:11-9. 10.1056\/NEJMoa1215340","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1800410","article-title":"Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA","volume":"379","author":"Johnston SC","year":"2018","unstructured":"Johnston SC, Easton JD, Farrant M, et al.. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N Engl J Med. 2018, 379:215-25. 10.1056\/NEJMoa1800410","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/eci.14209","article-title":"Single versus dual antiplatelet therapy following percutaneous left atrial appendage closure-a systematic review and meta-analysis","volume":"54","author":"Continisio S","year":"2024","unstructured":"Continisio S, Montonati C, Angelini F, et al.. Single versus dual antiplatelet therapy following percutaneous left atrial appendage closure-a systematic review and meta-analysis. Eur J Clin Invest. 2024, 54:e14209. 10.1111\/eci.14209","journal-title":"Eur J Clin Invest"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2020.10.016","article-title":"Single versus dual antiplatelet therapy following TAVR: a systematic review and meta-analysis of randomized controlled trials","volume":"14","author":"Guedeney P","year":"2021","unstructured":"Guedeney P, Sorrentino S, Mesnier J, et al.. Single versus dual antiplatelet therapy following TAVR: a systematic review and meta-analysis of randomized controlled trials. JACC Cardiovasc Interv. 2021, 14:234-6. 10.1016\/j.jcin.2020.10.016","journal-title":"JACC Cardiovasc Interv"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k5108","article-title":"Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis","volume":"363","author":"Hao Q","year":"2018","unstructured":"Hao Q, Tampi M, O'Donnell M, Foroutan F, Siemieniuk RA, Guyatt G. Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis. BMJ. 2018, 363:k5108. 10.1136\/bmj.k5108","journal-title":"BMJ"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1159\/000490307","article-title":"Single versus dual antiplatelet therapy after transcatheter aortic valve implantation: a systematic review and meta-analysis","volume":"141","author":"Hu X","year":"2018","unstructured":"Hu X, Yang FY, Wang Y, Zhang Y, Chen M. Single versus dual antiplatelet therapy after transcatheter aortic valve implantation: a systematic review and meta-analysis. Cardiology. 2018, 141:52-65. 10.1159\/000490307","journal-title":"Cardiology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2019.12.070","article-title":"Dual versus single antiplatelet therapy in carotid artery endarterectomy: direct comparison of complications related to antiplatelet therapy","volume":"135","author":"Jiang QL","year":"2020","unstructured":"Jiang QL, Wang PJ, Liu HX, Huang LL, Kang XK. Dual versus single antiplatelet therapy in carotid artery endarterectomy: direct comparison of complications related to antiplatelet therapy. World Neurosurg. 2020, 135:e598-609. 10.1016\/j.wneu.2019.12.070","journal-title":"World Neurosurg"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.11735","article-title":"Comparison of dual antiplatelet therapies for minor, nondisabling, acute ischemic stroke: a Bayesian network meta-analysis","volume":"7","author":"Lim A","year":"2024","unstructured":"Lim A, Ma H, Ly J, et al.. Comparison of dual antiplatelet therapies for minor, nondisabling, acute ischemic stroke: a Bayesian network meta-analysis. JAMA Netw Open. 2024, 7:e2411735. 10.1001\/jamanetworkopen.2024.11735","journal-title":"JAMA Netw Open"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2021.4514","article-title":"Comparison of ticagrelor vs clopidogrel in addition to aspirin in patients with minor ischemic stroke and transient ischemic attack: a network meta-analysis","volume":"79","author":"Lun R","year":"2022","unstructured":"Lun R, Dhaliwal S, Zitikyte G, Roy DC, Hutton B, Dowlatshahi D. Comparison of ticagrelor vs clopidogrel in addition to aspirin in patients with minor ischemic stroke and transient ischemic attack: a network meta-analysis. JAMA Neurol. 2022, 79:141-8. 10.1001\/jamaneurol.2021.4514","journal-title":"JAMA Neurol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.26867","article-title":"Diagnosis and management of transient ischemic attack and acute ischemic stroke: a review","volume":"325","author":"Mendelson SJ","year":"2021","unstructured":"Mendelson SJ, Prabhakaran S. Diagnosis and management of transient ischemic attack and acute ischemic stroke: a review. JAMA. 2021, 325:1088-98. 10.1001\/jama.2020.26867","journal-title":"JAMA"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2022.101269","article-title":"Single versus dual antiplatelet therapy following left atrial appendage occlusion in patients with high bleeding risk","volume":"47","author":"Mhanna M","year":"2022","unstructured":"Mhanna M, Beran A, Al-Abdouh A, et al.. Single versus dual antiplatelet therapy following left atrial appendage occlusion in patients with high bleeding risk. Curr Probl Cardiol. 2022, 47:101269. 10.1016\/j.cpcardiol.2022.101269","journal-title":"Curr Probl Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.011696","article-title":"Impact of smoking status on stroke recurrence","volume":"8","author":"Chen J","year":"2019","unstructured":"Chen J, Li S, Zheng K, et al.. Impact of smoking status on stroke recurrence. J Am Heart Assoc. 2019, 8:e011696. 10.1161\/JAHA.118.011696","journal-title":"J Am Heart Assoc"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/01.JAA.0000892756.17928.30","article-title":"Dual antiplatelet therapy for minor ischemic stroke and transient ischemic attack","volume":"35","author":"Miller B","year":"2022","unstructured":"Miller B, Shealy KM. Dual antiplatelet therapy for minor ischemic stroke and transient ischemic attack. JAAPA. 2022, 35:10-1. 10.1097\/01.JAA.0000892756.17928.30","journal-title":"JAAPA"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1055\/s-0045-1802551","article-title":"Dual versus single antiplatelet therapy in patients with nonminor ischemic stroke: a meta-analysis","volume":"83","author":"M\u00f4ro IO","year":"2025","unstructured":"M\u00f4ro IO, Marinheiro G, Leite M, Monteiro GA, Pinheiro AC, Telles JP. Dual versus single antiplatelet therapy in patients with nonminor ischemic stroke: a meta-analysis. Arq Neuropsiquiatr. 2025, 83:1-10. 10.1055\/s-0045-1802551","journal-title":"Arq Neuropsiquiatr"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.carrev.2021.11.003","article-title":"Dual versus single antiplatelet therapy after TAVR: let's not mix apples and oranges","volume":"34","author":"Nicolas J","year":"2022","unstructured":"Nicolas J, Dangas G. Dual versus single antiplatelet therapy after TAVR: let's not mix apples and oranges. Cardiovasc Revasc Med. 2022, 34:54-5. 10.1016\/j.carrev.2021.11.003","journal-title":"Cardiovasc Revasc Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.122.039900","article-title":"Dual antiplatelet therapy with cilostazol for secondary prevention in lacunar stroke: subanalysis of the CSPS.com trial","volume":"54","author":"Nishiyama Y","year":"2023","unstructured":"Nishiyama Y, Kimura K, Otsuka T, et al.. Dual antiplatelet therapy with cilostazol for secondary prevention in lacunar stroke: subanalysis of the CSPS.com trial. Stroke. 2023, 54:697-705. 10.1161\/STROKEAHA.122.039900","journal-title":"Stroke"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2019.2531","article-title":"Outcomes associated with clopidogrel-aspirin use in minor stroke or transient ischemic attack: a pooled analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) trials","volume":"76","author":"Pan Y","year":"2019","unstructured":"Pan Y, Elm JJ, Li H, et al.. Outcomes associated with clopidogrel-aspirin use in minor stroke or transient ischemic attack: a pooled analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) trials. JAMA Neurol. 2019, 76:1466-73. 10.1001\/jamaneurol.2019.2531","journal-title":"JAMA Neurol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s10840-022-01347-1","article-title":"Dual therapy with oral anticoagulation and single antiplatelet agent versus monotherapy with oral anticoagulation alone in patients with atrial fibrillation and stable ischemic heart disease: a systematic review and meta-analysis","volume":"66","author":"Shakir A","year":"2023","unstructured":"Shakir A, Khan A, Agarwal S, et al.. Dual therapy with oral anticoagulation and single antiplatelet agent versus monotherapy with oral anticoagulation alone in patients with atrial fibrillation and stable ischemic heart disease: a systematic review and meta-analysis. J Interv Card Electrophysiol. 2023, 66:493-506. 10.1007\/s10840-022-01347-1","journal-title":"J Interv Card Electrophysiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2024.0133","article-title":"Ticagrelor or clopidogrel monotherapy vs dual antiplatelet therapy after percutaneous coronary intervention: a systematic review and patient-level meta-analysis","volume":"9","author":"Valgimigli M","year":"2024","unstructured":"Valgimigli M, Gragnano F, Branca M, et al.. Ticagrelor or clopidogrel monotherapy vs dual antiplatelet therapy after percutaneous coronary intervention: a systematic review and patient-level meta-analysis. JAMA Cardiol. 2024, 9:437-48. 10.1001\/jamacardio.2024.0133","journal-title":"JAMA Cardiol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01616-7","article-title":"De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials","volume":"404","author":"Valgimigli M","year":"2024","unstructured":"Valgimigli M, Hong SJ, Gragnano F, et al.. De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials. Lancet. 2024, 404:937-48. 10.1016\/S0140-6736(24)01616-7","journal-title":"Lancet"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26287","article-title":"Bleeding risk of dual antiplatelet therapy after minor stroke or transient ischemic attack","volume":"91","author":"Wang A","year":"2022","unstructured":"Wang A, Meng X, Tian X, et al.. Bleeding risk of dual antiplatelet therapy after minor stroke or transient ischemic attack. Ann Neurol. 2022, 91:380-8. 10.1002\/ana.26287","journal-title":"Ann Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/383898-comparative-effectiveness-of-dual-antiplatelet-therapy-versus-single-antiplatelet-therapy-in-patients-with-acute-stroke","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T06:12:47Z","timestamp":1752214367000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/383898-comparative-effectiveness-of-dual-antiplatelet-therapy-versus-single-antiplatelet-therapy-in-patients-with-acute-stroke"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.87701","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,10]]}}}